Ajanta Pharma promoter Aayush Agrawal pledged 9,20,000 equity shares of the company to 360 One Prime Ltd on August 21, 2026. The move was made to provide additional security, following the release of a pledge on 9,76,000 shares on August 19, 2026, for loan repayment.

The disclosure was filed with the Bombay Stock Exchange and National Stock Exchange on August 27, 2026, under Regulation 31(1) and 31(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Pledge Transaction Details

Aayush Agrawal, acting as trustee for the Aayush Agrawal Trust, executed two separate encumbrance events within a week. The initial release of shares reduced the pledged holding with RBL Bank Ltd, while the subsequent creation increased exposure with 360 One Prime Ltd.

Promoter Holding Structure

As on the reporting date, the total promoter holding in Ajanta Pharma stands at 4,58,03,373 shares, representing 36.64% of the total share capital. This figure aggregates holdings across various entities and individuals associated with the promoter group.

The Aayush Agrawal Trust holds 1,41,12,924 shares (11.29%). Post-transaction, 1,34,76,924 shares (10.79%) from this block remain encumbered. Other significant promoter entities include Yogesh M Agrawal Trust and Rajesh M Agrawal Trust, each holding 1,80,78,147 shares (14.47%), none of which are currently encumbered.

What the Numbers Show

The net change in pledged shares for the Aayush Agrawal Trust is a reduction of 56,000 shares. However, the counterparty shifted from RBL Bank Ltd to 360 One Prime Ltd. This indicates a restructuring of collateral arrangements rather than a simple deleveraging event, as new debt or security requirements were met by re-pledging nearly all released shares.

Ravi Agrawal, acting as trustee for the Ravi Agrawal Trust, has released pledge on 6,910 equity shares of Ajanta Pharma . The promoter disclosed the transaction to the Bombay Stock Exchange and the National Stock Exchange on August 19, 2026, citing "Excess Pledge" as the primary reason for the release.

This latest disclosure follows a series of unpledging activities in early August 2026, which reduced the total encumbered stake held by the trust from 1,535,096 (1.23% of total share capital) to 1,480,300 (1.18% of total share capital) as of August 12. As per the disclosure under Regulation 31(1) and 31(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, the shares were pledged against business financing obligations.

Transaction Details

The most recent release of encumbrance occurred on August 19, 2026. This transaction adds to the cumulative reduction in pledged shares observed over the preceding two weeks.

Previous transactions were facilitated through Barclays Securities (India) Private Limited as the depository participant.

Promoter Holding Structure

The disclosure table provides a snapshot of the broader promoter group holdings as of the reporting date. While Ravi Agrawal’s trust saw a reduction in pledged stakes, other promoters maintained their positions:

• Gabs Investments Pvt Ltd: Holds 12,588,393 shares (10.07%), with 2,770,000 shares (2.22%) remaining encumbered.
• Yogesh M Agrawal (Trustee): Holds 18,078,147 shares (14.47%) with no encumbrances.
• Rajesh M Agrawal (Trustee): Holds 18,078,148 shares (14.47%) with no encumbrances.
• Aayush M Agrawal (Trustee): Holds 14,112,924 shares (11.29%), with a significant portion of 13,532,924 shares (10.83%) still encumbered.

Ganga Exports, represented by partners Yogesh Agrawal, Rajesh Agrawal, and Ravi Agrawal, holds 3,348,261 shares (2.68%) with no pledges reported.